Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,007 INR | -2.00% | +0.18% | +24.18% |
04-09 | Natco Pharma Gets US FDA Warning Letter after Inspection of Kothur, India Unit | MT |
03-27 | NATCO Pharma Limited Announces Board Appointments | CI |
Sales 2024 * | 39.19B 470M 37.5B | Sales 2025 * | 45.13B 541M 43.19B | Capitalization | 184B 2.21B 176B |
---|---|---|---|---|---|
Net income 2024 * | 13.21B 158M 12.64B | Net income 2025 * | 15.27B 183M 14.62B | EV / Sales 2024 * | 4.3 x |
Net cash position 2024 * | 15.67B 188M 14.99B | Net cash position 2025 * | 31.57B 378M 30.21B | EV / Sales 2025 * | 3.38 x |
P/E ratio 2024 * |
14
x | P/E ratio 2025 * |
12.2
x | Employees | 3,946 |
Yield 2024 * |
0.98% | Yield 2025 * |
1.1% | Free-Float | 46.76% |
Latest transcript on NATCO Pharma Limited
1 day | -1.98% | ||
1 week | +0.18% | ||
Current month | +5.82% | ||
1 month | +3.47% | ||
3 months | +14.49% | ||
6 months | +26.71% | ||
Current year | +24.18% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 46 | 02/07/00 | |
Founder | 78 | 18/09/81 | |
Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 78 | 18/09/81 | |
Chief Executive Officer | 46 | 02/07/00 | |
Director/Board Member | 70 | 17/04/14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 4 M€ | -4.41% | - | |
0.01% | 117 M€ | +1.11% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
29/04/24 | 1,007 | -2.00% | 439 450 |
26/04/24 | 1,028 | +0.66% | 1,157,262 |
25/04/24 | 1,021 | +2.26% | 1,288,313 |
24/04/24 | 998.6 | -2.37% | 367,850 |
23/04/24 | 1,023 | +1.70% | 639,513 |
Delayed Quote NSE India S.E., April 29, 2024 at 10:53 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.18% | 2.21B | |
+25.83% | 661B | |
+26.49% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.85% | 231B | |
+5.03% | 200B | |
-8.96% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- NATCOPHARM Stock